title: Effect of valsartan-eluting stents on the expression of angiotensin II type 2 receptor.
authors.affiliation: Cardiovascular Center of Beijing Friendship Hospital, Capital University of Medicine Sciences, Beijing 100050, China. wanglei@china.com
authors.forename: Lei
authors.initials: L
authors.lastname: Wang
authors.forename: Gui-hua
authors.initials: GH
authors.lastname: Li
authors.forename: Hui
authors.initials: H
authors.lastname: Chen
authors.forename: Hong-wei
authors.initials: HW
authors.lastname: Li
authors.forename: Lin
authors.initials: L
authors.lastname: Zhao
authors.forename: Dao-kuo
authors.initials: DK
authors.lastname: Yao
authors.forename: Rong-jing
authors.initials: RJ
authors.lastname: Ding
authors.forename: San-qing
authors.initials: SQ
authors.lastname: Jia
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000008:administration & dosage*; D000818:Animals; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000517:prevention & control; D003331:Coronary Vessels / Q000473:pathology; D016503:Drug Delivery Systems; D007150:Immunohistochemistry; D011817:Rabbits; D044140:Receptor, Angiotensin, Type 1 / Q000032:analysis; D044139:Receptor, Angiotensin, Type 2 / Q000032:analysis* / Q000235:genetics / Q000502:physiology; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015607:Stents; D013777:Tetrazoles / Q000008:administration & dosage*; D014633:Valine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000068756:Valsartan
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D044140:Receptor, Angiotensin, Type 1; D044139:Receptor, Angiotensin, Type 2; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine